Return On Equity of Inozyme Pharma, Inc. from 31 Dec 2019 to 31 Mar 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Inozyme Pharma, Inc. quarterly and annual Return On Equity in % history and change rate from 31 Dec 2019 to 31 Mar 2025.
  • Inozyme Pharma, Inc. Return On Equity for the quarter ending 31 Mar 2025 was -160%, a 172% decline year-over-year.
  • Inozyme Pharma, Inc. annual Return On Equity for 2024 was -115%, a 106% decline from 2023.
  • Inozyme Pharma, Inc. annual Return On Equity for 2023 was -56%, a 3.4% decline from 2022.
  • Inozyme Pharma, Inc. annual Return On Equity for 2022 was -54%, a 25% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Inozyme Pharma, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q1 2025 -160% -101% -172% 01 Jan 2025 31 Mar 2025
Q4 2024 -115% -59% -106% 01 Oct 2024 31 Dec 2024
Q3 2024 -88% -32% -58% 01 Jul 2024 30 Sep 2024
Q2 2024 -69% -10% -17% 01 Apr 2024 30 Jun 2024
Q1 2024 -59% -5% -9.9% 01 Jan 2024 31 Mar 2024
Q4 2023 -56% -2% -3.4% 01 Oct 2023 31 Dec 2023
Q3 2023 -56% -1% -1.3% 01 Jul 2023 30 Sep 2023
Q2 2023 -59% -4% -7.9% 01 Apr 2023 30 Jun 2023
Q1 2023 -53% 0% -0.08% 01 Jan 2023 31 Mar 2023
Q4 2022 -54% -11% -25% 01 Oct 2022 31 Dec 2022
Q3 2022 -55% -21% -61% 01 Jul 2022 30 Sep 2022
Q2 2022 -54% -14% -33% 01 Apr 2022 30 Jun 2022
Q1 2022 -53% +3% +5% 01 Jan 2022 31 Mar 2022
Q4 2021 -43% +53% +55% 01 Oct 2021 31 Dec 2021
Q3 2021 -34% +438% +93% 01 Jul 2021 30 Sep 2021
Q2 2021 -41% -115% -156% 01 Apr 2021 30 Jun 2021
Q1 2021 -56% -129% -177% 01 Jan 2021 31 Mar 2021
Q4 2020 -96% -174% -224% 01 Oct 2020 31 Dec 2020
Q3 2020 -473% 01 Jul 2020 30 Sep 2020
Q2 2020 74% 01 Apr 2020 30 Jun 2020
Q1 2020 73% 01 Jan 2020 31 Mar 2020
Q4 2019 78% 01 Oct 2019 31 Dec 2019

Inozyme Pharma, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -115% -59% -106% 01 Jan 2024 31 Dec 2024
2023 -56% -2% -3.4% 01 Jan 2023 31 Dec 2023
2022 -54% -11% -25% 01 Jan 2022 31 Dec 2022
2021 -43% +53% +55% 01 Jan 2021 31 Dec 2021
2020 -96% -174% -224% 01 Jan 2020 31 Dec 2020
2019 78% 01 Jan 2019 31 Dec 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.